Skip to main content
SpringerLink
Log in

Pharmacological Treatment of Insomnia

  • Chapter
Clinical Handbook of Insomnia

Part of the book series: Current Clinical Neurology ((CCNEU))

  • 261 Accesses

Abstract

Insomnia is the most common sleep-related complaint and the second most common overall complaint (after pain) reported in primary care settings. It affects 35% of the general population, according to the 1984 report of the National Institutes of Mental Health (1). Insomnia is not defined by total sleep time but by the inability to obtain sleep of sufficient length or quality to produce refreshment the following morning. For example, a person who needs only 4 hours of sleep does not have insomnia if he or she is refreshed in the morning after having 4 hours of sleep, whereas someone who needs 10 hours of sleep may have insomnia if he or she does not feel refreshed even after 8 hours of sleep. Contrary to popular lore, psychiatric or psychological factors are not the most frequent causes of insomnia. Insomnias can be divided into two major categories: the primary insomnias and the secondary insomnias. As discussed elsewhere in this volume, primary insomnias are conditions in which the insomnia is the main pathophysiological process, whereas secondary insomnias are conditions where the insomnia is a symptom of another disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. NIH Consensus Development Conference Summary. (1984) Drugs and insomnia: the use of medication to promote sleep. JAMA 251 (18), 2410–2414.

    Google Scholar 

  2. Gauillard, J. Cheref, S., Vacherontrystram, M. N., and Martin, J. C. (2002) [Chloral hydrate: a hypnotic best forgotten?]. Encephale 28(3 Pt 1 ), 200–204.

    Google Scholar 

  3. Wyatt, R. J., Engelman, K., Kupfer, O. J., Fram, D. H., Sjverdsma, A., Snyder, F. (1970) Effects of L-tryptophan (a natural sedative) on human sleep. Lancet 2 (7678), 842–846.

    Article  PubMed  CAS  Google Scholar 

  4. Glickstein, S. L., Gertner, E., Smith, S. A., et al. (1990) Eosinophilia-myalgia syndrome associated with L-tryptophan use. J. Rheumatol. 17 (11), 1534–1543.

    PubMed  CAS  Google Scholar 

  5. Marks, D. R. (1990) A case of L-tryptophan-induced eosinophilia-myalgia resulting in death. Conn. Med. 54 (10), 552–554.

    PubMed  CAS  Google Scholar 

  6. Zollner, N., Sorg, M., and Kruger, K. (1990) [Eosinophilia myalgia syndrome in administration of L-tryptophan]. Klin. Wochenschr. 68(14) 739–742.

    Google Scholar 

  7. Roehrs, T., Hollebeek, E., Drake, C., and Roth, T. (2002) Substance use for insomnia in Metropolitan Detroit. J. Psychosom. Res. 53 (1), 571–576.

    Article  PubMed  Google Scholar 

  8. Weiler, J. M., Bloomfield, J. R., Woodsworth, G. G., et al. (2000) Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. Ann. Intern. Med. 132 (5), 354–363.

    PubMed  CAS  Google Scholar 

  9. Basu, R., Dodge, H., Stoehr, G. P., Ganguli, M. (2003) Sedative-hypnotic use of diphenhydramine in a rural, older adult, community-based cohort: effects on cognition. Am. J. Geriatr. Psychiatry 11 (2), 205–213.

    PubMed  Google Scholar 

  10. Gilhooly, T. C., Webster, M. G., Poole, N. W., Ross, S. (1998) What happens when doctors stop prescribing temazepam? Use of alternative therapies. Br. J. Gen. Pract. 48 (434), 1601–1602.

    PubMed  CAS  Google Scholar 

  11. Sproule, B. A., Busto, U. E., Buckle, C., Herrmann, N., and Bowles, S. (1999) The use of nonprescription sleep products in the elderly. Int. J. Geriatr. Psychiatry 14 (10), 851–857.

    Article  PubMed  CAS  Google Scholar 

  12. Zhdanova, I. V., Wurtman, R. J., Regan, M. M., Taylor, J. A., Shi, J. P., Leclair, O. U. (2001) Melatonin treatment for age-related insomnia. J. Clin. Endocrinol. Metab. 86 (10), 4727–4730.

    Article  PubMed  CAS  Google Scholar 

  13. Smits, M. G., Nagtegaal, E. E., van der heijden, j., Coenen, A. M. and Kerkhof, G. A. (2001) Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial. J. Child. Neurol. 16 (2), 86–92.

    CAS  Google Scholar 

  14. Shamir, E., Landon, M., Barak, Y., et al. (2000) Melatonin improves sleep quality of patients with chronic schizophrenia. J. Clin. Psychiatry 61 (5), 373–377.

    Article  PubMed  CAS  Google Scholar 

  15. Sack, R. L., Lewy, A. J. and Hughes, R. J. (1998) Use of melatonin for sleep and circadian rhythm disorders. Ann. Med. 30 (1), 115–121.

    Article  PubMed  CAS  Google Scholar 

  16. Arendt, J. (1998) Complex effects of melatonin. Therapie 53 (5), 479–488.

    PubMed  CAS  Google Scholar 

  17. Olde Rikkert, M. G. and Rigaud, A. S. (2001) Melatonin in elderly patients with insomnia. A systematic review. Z. Gerontol. Geriatr. 34 (6), 491–497.

    Article  PubMed  CAS  Google Scholar 

  18. Stone, B. M., Turner, C., Mills, S. L, and Nicholson, A. N. (2000) Hypnotic activity of melatonin. Sleep 23 (5), 663–669.

    PubMed  CAS  Google Scholar 

  19. Dominguez, R. A., Bravo-Valverde, R. L., Kaplowitz, B. C., and Cott, J. M. (2000) Valerian as a hypnotic for Hispanic patients. Cultur. Divers. Ethnic Minor. Psychol. 6 (1), 84–92.

    Article  PubMed  CAS  Google Scholar 

  20. Donath, F., Quispe, S., Diefenbach, K., Maurer, A., Fietze, I., and Roots, I. (2000) Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry 33 (2), 47–53.

    Article  PubMed  CAS  Google Scholar 

  21. Fussel, A., Wolf, A., and Brattstrom, A. (2000) Effect of a fixed valerian-Hop extract combination (Ze 91019) on sleep polygraphy in patients with non-organic insomnia: a pilot study. Eur. J. Med. Res. 5 (9), 385–390.

    PubMed  CAS  Google Scholar 

  22. Dorn, M. (2000) [Efficacy and tolerability of Baldrian versus oxazepam in non-organic and non-psychiatric insomniacs: a randomised, double-blind, clinical, comparative study]. Forsch. Komplementarmed. Klass. Naturheilkd. 7(2) 79–84.

    Google Scholar 

  23. Ziegler, G., Ploch, M., Miettinern-Baumann, A., Collet, W. (2002) Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia: a randomized, double-blind, comparative clinical study. Eur. J. Med. Res. 7 (11), 480–486.

    PubMed  CAS  Google Scholar 

  24. Carvalho-Freitas, M. I. and Costa, M. (2002) Anxiolytic and Sedative Effects of Extracts and Essential Oil from Citrus aurantium L. Biol. Pharm. Bull. 25 (12), 1629–1633.

    Article  PubMed  CAS  Google Scholar 

  25. Chung, K. F. and Lee, C. K. (2002) Over-the-counter sleeping pills: a survey of use in Hong Kong and a review of their constituents. Gen. Hosp. Psychiatry 24 (6), 430–435.

    Article  PubMed  Google Scholar 

  26. Walsh, J. K. and Schweitzer, P. K. (1999) Ten-year trends in the pharmacological treatment of insomnia. Sleep 22 (3), 371–375.

    PubMed  CAS  Google Scholar 

  27. Scharf, M. B. and Sachais, B. A. (1990) Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients. J. Clin. Psychiatry 51 (Suppl), 13–17.

    PubMed  Google Scholar 

  28. Mashiko, H., Niwa, S., Kumashiro, H., et al. (1999) Effect of trazodone in a single dose before bedtime for sleep disorders accompanied by a depressive state: dose-finding study with no concomitant use of hypnotic agent. Psychiatry Clin. Neurosci. 53 (2), 193–194.

    Article  PubMed  CAS  Google Scholar 

  29. Parrino, L., Spaggiari, M. C., Boselli, M., DiGiovanni, G., and Terzano, M. G. (1994) Clinical and polysomnographic effects of trazodone CR in chronic insomnia associated with dysthymia. Psychopharmacology (Berl.) 116 (4), 389–395.

    Article  CAS  Google Scholar 

  30. Kallepalli, B. R., Bhatara, V. S., Fogas, B. S., Tervo, R. C., and Misra, L. K. (1997) Trazodone is only slightly faster than fluoxetine in relieving insomnia in adolescents with depressive disorders. J. Child. Adolesc. Psychopharmacol. 7 (2), 97–107.

    Article  PubMed  CAS  Google Scholar 

  31. Metz, A. and Shader, R. I. (1990) Adverse interactions encountered when using trazodone to treat insomnia associated with fluoxetine. Int. Clin. Psychopharmacol. 5 (3), 191–194.

    Article  PubMed  CAS  Google Scholar 

  32. Montgomery, I., Oswald, I., Morgan, K., and Adam, K. (1983) Trazodone enhances sleep in subjective quality but not in objective duration. Br. J. Clin. Pharmacol. 16 (2), 139–144.

    Article  PubMed  CAS  Google Scholar 

  33. Riemann, D., Voderholzer, U., Cohrs, S., et al. (2002) Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study. Pharmacopsychiatry 35 (5), 165–174.

    Article  PubMed  CAS  Google Scholar 

  34. Terzano, M. G., Rossi, M., Palomba, V., Smerieri, A., and Parrino, L. (2003) New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf. 26 (4), 261–282.

    Article  PubMed  CAS  Google Scholar 

  35. Holbrook, A. M., Crowther, R., Lotter, A., Chang, K., and King, D. (2000) Meta-analysis of benzodiazepine use in the treatment of insomnia. Cmaj 162 (2), 225–233.

    PubMed  CAS  Google Scholar 

  36. Mendelson, W. B., Thompson, C., and Franko, T. (1996) Adverse reactions to sedative/hypnotics: three years’ experience. Sleep 19 (9), 702–706.

    PubMed  CAS  Google Scholar 

  37. Morin, C. M., Bastien, C. H., Brink, D., and Brown, T. R. (2003) Adverse effects of temazepam in older adults with chronic insomnia. Hum. Psychopharmacol. 18 (1), 75–82.

    Article  PubMed  CAS  Google Scholar 

  38. Taylor, F. K. (1989) The damnation of benzodiazepines. Br. J. Psychiatry 154, 697–704.

    Article  PubMed  CAS  Google Scholar 

  39. Roehrs, T., Pedrosi, B., Rosenthal, L., and Roth, T. (1996) Hypnotic self administration and dose escalation. Psychopharmacology (Berl.) 127 (2), 150–154.

    Article  CAS  Google Scholar 

  40. Schenck, C. H. and Mahowald, M. W. (1996) Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am. J. Med. 100 (3), 333–337.

    Article  PubMed  CAS  Google Scholar 

  41. Schlich, D., L’Heritier, C., Coquelin, J. P., Attali, P., and Kryrein, H. J. (1991) Long-term treatment of insomnia with zolpidem: a multicentre general practitioner study of 107 patients. J. Int. Med. Res. 19 (3), 271–279.

    PubMed  CAS  Google Scholar 

  42. Maarek, L., Cramer, P., Attali, P., Coquelin, J. P., and Morselli, P. L. (1992) The safety and efficacy of zolpidem in insomniac patients: a long-term open study in general practice. J. Int. Med. Res. 20 (2), 162–170.

    PubMed  CAS  Google Scholar 

  43. Saletu-Zyhlarz, G., Anderer, P., Brandstatter, N., et al. (2000) Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder. Neuropsychobiology 41 (3), 139–148.

    Article  PubMed  CAS  Google Scholar 

  44. Israel, A. G. and Kramer, J. A. (2002) Safety of zaleplon in the treatment of insomnia. Ann. Pharmacother. 36 (5), 852–859.

    Article  PubMed  CAS  Google Scholar 

  45. Fry, J., Scharf, M., Mangano, R., and Fujimori, M. (2000) Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Zaleplon Clinical Study Group. Int. Clin. Psychopharmacol. 15 (3), 141–152.

    Article  PubMed  CAS  Google Scholar 

  46. Hedner, J., Yaechi, R., Emilien, G., Farr, I. and Salinas, E. (2000) Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group. Int. J. Geriatr. Psychiatry 15 (8), 704–712.

    Article  PubMed  CAS  Google Scholar 

  47. Walsh, J. K., Pollak, C. P., Scharf, M. B., Schweitzer, P. K., and Vogel, G. W. (2000) Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia. Clin. Neuropharmacol. 23 (1), 17–21.

    Article  PubMed  CAS  Google Scholar 

  48. Quera-Salva, M. A., Philip, P., Taillard, J., et al. (2002) [Study of the real situation of improvement by Zopiclone in treatment of insomnia among persons working during night shifts]. Rev. Neurol. (Paris) 158(11) 1102–1106.

    Google Scholar 

  49. Hajak, G., Bardelow, B., Zulley, J., and Pittrow, D. (2002) “As needed” pharmacotherapy combined with stimulus control treatment in chronic insomnia—assessment of a novel intervention strategy in a primary care setting. Ann. Clin. Psychiatry 14(1), 1–7.

    Google Scholar 

  50. Hajak, G., Cluydts, R., Dederck, A., et al. (2002) Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study. Int. Clin. Psychopharmacol. 17 (1), 9–17.

    Article  PubMed  CAS  Google Scholar 

  51. Becker, P. M., Ondo, W., and Sharon, D. (1998) Encouraging initial response of restless legs syndrome to pramipexole. Neurology 51 (4), 1221–1223.

    Article  PubMed  CAS  Google Scholar 

  52. Lin, S. C., kaplan, J., Burger, C., D., and Fredrickson, P. A. (1998) Effect of pramipexole in treatment of resistant restless legs syndrome. Mayo Clin. Proc. 73 (6), 497–500.

    Article  PubMed  CAS  Google Scholar 

  53. Saletu, B., Gruber, G., Saletu, B., et al. (2000) Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality. Neuropsychobiology 41 (4), 181–189.

    Article  PubMed  CAS  Google Scholar 

  54. Saletu, M., Anderer, P., Saletu, B., et al. (2000) Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variables. Neuropsychobiology 41 (4), 190–199.

    Article  PubMed  CAS  Google Scholar 

  55. Wetter, T. C., Stjasny, K., Winkelmann, J., et al. (1999) A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 52 (5), 944–950.

    Article  PubMed  CAS  Google Scholar 

  56. Brodeur, C., Montplaisir, J., Godbout, R., and Mariner, R. (1998) Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study. Neurology 38 (12), 1845–1848.

    Article  Google Scholar 

  57. Walters, A. S., Wagner, M. L., Hening, W, A,, et al. (1993) Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 16 (4), 327–332.

    PubMed  CAS  Google Scholar 

  58. Peled, R. and Lavie, P. (1987) Double-blind evaluation of clonazepam on periodic leg movements in sleep. J. Neurol. Neurosurg. Psychiatry 50 (12), 1679–1681.

    Article  PubMed  CAS  Google Scholar 

  59. Happe, S., Klosch, G., Saletu, B., and Zeitlhofer, J. (2000) Treatment of idiopathic restless legs syndrome (RLS) with gabapentin. Neurology 57 (9), 1717–1719.

    Article  Google Scholar 

  60. Garcia-Borreguero, D., Larrosa, O., de la Llave, Y., Verger, K., Masramon, X., and Hernandez G. (2002) Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 59 (10), 1573–1579.

    Article  PubMed  CAS  Google Scholar 

  61. Wagner, M. L., Walters, A. S., Coleman, R. G., Hening, W. A., Grasing, K., and Chokroverty, S. (1996) Randomized, double-blind, placebo-controlled study of clonidine in restless legs syndrome. Sleep 19 (1), 52–58.

    PubMed  CAS  Google Scholar 

  62. Moe, K. E. (1999) Reproductive hormones, aging, and sleep. Semin. Reprod. Endocrinol. 17 (4), 339–348.

    PubMed  CAS  Google Scholar 

  63. Polo-Kantola, P., Erkkola, R., Irjala, K., Pullinen, S., Virtanen, I., and Polo, O. (1999) Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal women. Fertil. Steril. 71 (5), 873–880.

    Article  PubMed  CAS  Google Scholar 

  64. Mahady, G. B., Fabricant, D., Chadurch, L. R., and Diets, B. (2002) Black cohosh: an alternative therapy for menopause? Nutr. Clin. Care 5 (6), 283–289.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Hrayr P. Attarian
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Sleep Program in Neurology and Sleep Laboratory of the Clinical Neurophysiology Laboratories, University of Vermont College of Medicine, Burlington, VT, USA

    Hrayr P. Attarian MD

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Attarian, H.P. (2004). Pharmacological Treatment of Insomnia. In: Attarian, H.P. (eds) Clinical Handbook of Insomnia. Current Clinical Neurology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-662-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-662-1_14

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-465-4

  • Online ISBN: 978-1-59259-662-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation